IGM Biosciences, Inc. Deferred Revenue, Additions
IGM Biosciences, Inc. reported Deferred Revenue, Additions of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Income Statement › Other Income
us-gaap:DeferredRevenueAdditions · last filed 2025-03-06
- IGM Biosciences, Inc. deferred revenue, additions for fiscal 2024 was $0.00.
- IGM Biosciences, Inc. deferred revenue, additions for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- IGM Biosciences, Inc. deferred revenue, additions for fiscal 2022 was $150.00M.
| Period end | Deferred Revenue, Additions 12 month |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-06 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-06 |
| 2022-12-31 | $150.00M 10-K · filed 2024-03-07 |